Loading...
FDA Foreign Drug Inspection Program: A System at Risk
House Committee on Energy and Commerce ; Subcommittee on Oversight and Investigations
House Committee on Energy and Commerce
Subcommittee on Oversight and Investigations
Abstract
The House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations issued a Bipartisan Staff Report on FDA inspections of foreign drug producing firms.
Date
2007-10-30
Document Type
House Bipartisan Staff Report
Serial Number
Document Length
14 pages
Congress
110
Relation
DOI
Keywords
Bipartisan, Staff Reports, House
PAP Major Code
3: Health
PAP Minor Code
321: Regulation of Drug Industry, Medical Devices, and Clinical Labs
